JPRN-UMIN000011720已完成未知
Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind, Placebo-controlled Trial - Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind, Placebo-controlled Trial
Department of Psychiatry, Chiba University School of Medicine0 个研究点目标入组 40 人开始时间: 2013年9月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 13years-old 至 18years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •[Exclusion Criteria] 1) History of allergic reaction or hypersensitivity to Ifenprodil Tartrate. 2) Patients who have not stopped bleeding after intracranial hemorrhage. 3) Patients who have not been informed of having the disease at the time of informed consent. 4) Diagnosis of any of the following diseases based on the DSM-IV-TR criteria. Mental Retardation, Pervasive Developmental Disorders, Attention-Deficit / Hyperactivity Disorder, Schizophrenia and Other Psychotic Disorders, Delirium, Dementia, and Amnestic and Other Cognitive Disorders, Substance-Related Disorders (except Caffeine-Related Disorders, Nicotine-Related Disorders). 5) Somatic disorder which requires severe body management or severe meal management. 6) receiving treatment, with antidepressants, mood stabilizers, and atypical antipsychotics other than those of the inclusion criteria 4), within 4 weeks prior to enrollment in this study. 7) receiving treatment with the following N-methyl-D aspartate (NMDA) receptor antagonists: Ketamine hydrochloride, Amantadine hydrochloride, Memantine hydrochloride, dextromethorphan, Methadone) within 4 weeks prior to enrollment in this study. 8) pregnant or nursing, or intending to become pregnant or to start breastfeeding during the study. 9) participating in another clinical trial within 3 months prior to enrollment into this study. (except for observation study without intervention). 10) planning change of treatment because of unstable neurological manifestations or somatic symptoms. 11) History of suicidal ideation within the past year. 12) Other clinically significant reasons for exclusion by investigators.
研究者
相似试验
进行中（未招募）
不适用
TREATMENT STUDY FOR CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA - ICC APL STUDY 01EUCTR2008-002311-40-ITA.I.E.O.P. - ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA300
进行中（未招募）
1 期
IBD under control with less medicatioEUCTR2020-001811-26-NLniversity Medical Center Groningen150
招募中
4 期
De-escalation of anti-TNF therapy in adolescents and young adults with IBD with tight faecal calprotectin and trough level monitoringCrohn's diseaseulcerative colitisNL-OMON52654niversitair Medisch Centrum Groningen40
进行中（未招募）
1 期
IBD under control with less medicatioCrohn's disease, ulcerative colitisEUCTR2020-001811-26-BEniversity Medical Center Groningen148
进行中（未招募）
1 期
Treatment study for children and adolescents with Acute Promyelocytic LeukemiaEUCTR2017-002383-40-ITAIEOP- Associazione Italiana Ematologia Oncologia Pediatrica90